Skip to main content
Top

Current Hypertension Reports

Issue 3/2016

Content (7 Articles)

Novel Treatments for Hypertension (T Unger, Section Editor)

Personalized Therapy of Hypertension: the Past and the Future

Paolo Manunta, Mara Ferrandi, Daniele Cusi, Patrizia Ferrari, Jan Staessen, Giuseppe Bianchi

Hypertension and the Brain (S Stocker, Section Editor)

Neural Control of Blood Pressure in Chronic Intermittent Hypoxia

Brent Shell, Katelynn Faulk, J. Thomas Cunningham

Hypertension and the Brain (S Stocker, Section Editor)

Parasympathetic Vagal Control of Cardiac Function

Jhansi Dyavanapalli, Olga Dergacheva, Xin Wang, David Mendelowitz

Hypertension and Obesity (E Reisin, Section Editor)

Aldosterone Production and Signaling Dysregulation in Obesity

Andrea Vecchiola, Carlos F. Lagos, Cristian A. Carvajal, Rene Baudrand, Carlos E. Fardella

Hypertension and the Kidney (RM Carey, Section Editor)

Major Autonomic Neuroregulatory Pathways Underlying Short- and Long-Term Control of Cardiovascular Function

Ibrahim M. Salman

Pathogenesis of Hypertension (W Elliott and R Santos, Section Editors)

Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence

Antoine Caillon, Ernesto L. Schiffrin

Therapeutic Trials (M Weir, Section Editor)

Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?

Farhanah Yousaf, Bruce Spinowitz

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine